Concepedia

Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses

Bernard Côté, Jason D. Burch, Ernest Asante‐Appiah, Chris Bayly, Leanne L. Bedard, Marc Blouin, Louis‐Charles Campeau, Elizabeth Cauchon, Manuel Chan, Amandine Chefson,

Bioorganic & Medicinal Chemistry Letters · 2013 · 101 citations · 9 references

DOI

Concepts

References

9

Treatment for Adult HIV Infection

Scott M. Hammer, Michael S. Saag, Mauro Schechter et al. · JAMA · 2006 · 1K citations

, , +15

L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.

Joseph P. Vacca, Bruce D. Dorsey, William A. Schleif et al. · Proceedings of the National Academy of Sciences · 1994 · 526 citations

, , +17

Complexes of HIV-1 Reverse Transcriptase with Inhibitors of the HEPT Series Reveal Conformational Changes Relevant to the Design of Potent Non-Nucleoside Inhibitors

Andrew L. Hopkins, Jingshan Ren, Robert Esnouf et al. · Journal of Medicinal Chemistry · 1996 · 343 citations · Full text

, , +16

Lipid Profiles in HIV‐Infected Patients Receiving Combination Antiretroviral Therapy: Are Different Antiretroviral Drugs Associated with Different Lipid Profiles?

Éric Fontas, Frank van Leth, Caroline Sabin et al. · The Journal of Infectious Diseases · 2004 · 336 citations · Full text

, , +17

Compilation and prevalence of mutations associated with resistance to non-nucleoside reverse transcriptase inhibitors

Lotke Tambuyzer, Hilde Azijn, L Rimsky et al. · Antiviral Therapy · 2009 · 94 citations · Full text

, , +17